Award-winning aesthetic and beauty agencies Kendrick PR and Mantelpiece PR have teamed up to manage the UK PR for global aesthetic and pharmaceutical company, Galderma. The PR programme will be focusing on the Galderma injectables portfolio, including Sculptra, Restylane and the botulinum toxin brands (Azzalure/Dysport).
This joint initiative brings together two award-winning industry powerhouse agencies – working in tandem to support the Galderma aesthetics business. As specialists in aesthetics with over twenty years of combined experience, CEOs Julia Kendrick and Kate Zadah have an unparalleled approach and a strong network of industry and press relationships, which they will utilise alongside a blended team that unites the best of each agency to underpin the communications activities.
“We are delighted to be bringing together the best of Kendrick and Mantelpiece!” says Julia Kendrick. “This will be a comprehensive PR programme for a market-leading company and given our respective years of expertise and strong networks, Kate and I felt it was the ideal opportunity to work collaboratively to deliver some exciting and thought-provoking campaigns. Watch this space!”
Mantelpiece CEO Kate Zadah adds: “This collaboration is hugely exciting and I know I speak for both Julia and I when I say we’re looking forward to creating and implementing a whole host of impactful activities for Galderma next year.”